You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
29 March 2021
Enzymatica has warned that sales of its ColdZyme common cold spray may be lower in 2021 than in 2020 due to the impact of the COVID-19 pandemic.
19 January 2021
McKesson Europe has a new chief financial officer, Sweden’s Enzymatica has made changes to its management team, and the US Council for Responsible Nutrition (CRN) has a new chair.
9 December 2020
Germany’s Stada has inlicensed rights to Enzymatica’s ViruProtect common cold spray in the Nordic region excluding Sweden.
16 November 2020
MS Pharma is set to launch Enzymatica’s common cold spray, ColdZyme, under its registered trademarks in the Middle East and North Africa (MENA).
23 October 2020
Sanofi Consumer Healthcare is set to launch Enzymatica’s common cold spray, ColdZyme, under its established brands in France and Italy.
14 October 2020
Germany’s Stada has inlicensed exclusive rights to Enzymatica’s ViruProtect cold spray in an additional 14 countries including Poland, Russia and Ukraine.